2-(tert-Butyl)-4-chloro-6-phenyl-1,3,5-triazine

Catalog No. :
ACBWRJ486
CAS No. :
2690317-87-2
Molecular Formula :
C13H14ClN3
Molecular Weight :
247.73

IUPAC Name:2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine

2-(tert-Butyl)-4-chloro-6-phenyl-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$67.00Login to see priceIn stockInquiry
1g98%$174.00Login to see priceIn stockInquiry
5g98%$625.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl)-4-chloro-6-phenyl-1,3,5-triazine
IUPAC Name2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine
MDL No.-
Molecular FormulaC13H14ClN3
Molecular Weight247.73
SMILESClC1=NC(C2=CC=CC=C2)=NC(C(C)(C)C)=N1
InChI KeyAZCRBOTUMIELBT-UHFFFAOYSA-N
Synonym1,3,5-Triazine, 2-chloro-4-(1,1-dimethylethyl)-6-phenyl-;2-(tert-Butyl)-4-chloro-6-phenyl-1,3,5-triazine
CAS No.2690317-87-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBWRJ486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDLY291 route compound structure diagram
    ACWDLY291705-23-7 In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACBWRJ486 route product structure diagram
    ACBWRJ4862690317-87-2 In Stock
Inquiry

2. ACBWRJ486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDLY291 route compound structure diagram
    ACWDLY291705-23-7 In Stock
  2. Plus
  3. ACKBJO028 route compound structure diagram
    ACKBJO02824388-23-6 In Stock
  4. Then
  5. ACBWRJ486 route product structure diagram
    ACBWRJ4862690317-87-2 In Stock
Inquiry

Comments (0)